Korsana Biosciences, Inc. SEC filings KRSA
Korsana Biosciences, Inc. has 391 filings in SEC EDGAR's recent list, going back to Oct 9, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 11, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Aug 27, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Other events
|
Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Regulation FD disclosure
|
Apr 1, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 6, 2026 | Jan 3, 2026 |
| 8-K |
Current report
Other events
|
Dec 1, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 23, 2025 | Sep 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Material agreement
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 25, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 17, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Other events
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 4, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 24, 2023 | Nov 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 19, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Other events
|
Jul 12, 2023 | Jul 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Other events
|
Jun 1, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
May 25, 2023 | May 19, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
|
May 12, 2023 | May 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2022 | Nov 22, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Oct 6, 2022 | Oct 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 26, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 3, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2021 | Aug 18, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 4, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Agreement ended
|
May 4, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 27, 2021 | Apr 27, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 26, 2021 | Apr 21, 2021 |
| 8-K/A |
Amended current report
Other events
|
Mar 19, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Other events
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2021 | Jan 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 21, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Other events
|
Oct 14, 2020 | Oct 14, 2020 |
| 8-K |
Current report
Other events
|
Oct 1, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 3, 2020 | Sep 3, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2020 | Aug 3, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 9, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 18, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Apr 14, 2020 | Apr 10, 2020 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2020 | Feb 28, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Oct 30, 2019 | Oct 29, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2019 | Sep 23, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2019 | Aug 12, 2019 |
| 8-K |
Current report
Results of operations
|
May 13, 2019 | May 13, 2019 |
| 8-K |
Current report
Other events
|
Apr 9, 2019 | Apr 9, 2019 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 2, 2019 | Mar 29, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2019 | Mar 14, 2019 |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KRSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1755237
- Former names
- Cyclerion Therapeutics, Inc. (until Aug 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.